ATE347912T1 - Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik - Google Patents

Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik

Info

Publication number
ATE347912T1
ATE347912T1 AT02758379T AT02758379T ATE347912T1 AT E347912 T1 ATE347912 T1 AT E347912T1 AT 02758379 T AT02758379 T AT 02758379T AT 02758379 T AT02758379 T AT 02758379T AT E347912 T1 ATE347912 T1 AT E347912T1
Authority
AT
Austria
Prior art keywords
ionic
ray
combined
magnetic resonance
nuclear magnetic
Prior art date
Application number
AT02758379T
Other languages
English (en)
Inventor
Silvio Aime
Alessandro Barge
Valentina Mainero
Original Assignee
Bracco Imaging Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bracco Imaging Spa filed Critical Bracco Imaging Spa
Application granted granted Critical
Publication of ATE347912T1 publication Critical patent/ATE347912T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1806—Suspensions, emulsions, colloids, dispersions
    • A61K49/1812—Suspensions, emulsions, colloids, dispersions liposomes, polymersomes, e.g. immunoliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A61K49/0466—Liposomes, lipoprotein vesicles, e.g. HDL or LDL lipoproteins, phospholipidic or polymeric micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
AT02758379T 2001-08-03 2002-07-23 Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik ATE347912T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001706A ITMI20011706A1 (it) 2001-08-03 2001-08-03 Agenti di contrasto radiografici ionici e non ionici, utilizzabili per l'indagine diagnostica combinata tramite raggi-x e risonanza magnetic

Publications (1)

Publication Number Publication Date
ATE347912T1 true ATE347912T1 (de) 2007-01-15

Family

ID=11448229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02758379T ATE347912T1 (de) 2001-08-03 2002-07-23 Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik

Country Status (9)

Country Link
US (1) US8211404B2 (de)
EP (1) EP1411992B1 (de)
JP (1) JP4310187B2 (de)
AT (1) ATE347912T1 (de)
DE (1) DE60216770T2 (de)
DK (1) DK1411992T3 (de)
ES (1) ES2278946T3 (de)
IT (1) ITMI20011706A1 (de)
WO (1) WO2003013616A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2374633T3 (es) 2004-03-11 2012-02-20 Mallinckrodt Llc Formulación de contraste por rayos x que comprende una mezcla de monómero y dímero yodado.
DE102005028882A1 (de) * 2005-06-22 2007-01-04 Siemens Ag Lösung und Verfahren zum Unterstützen der Bildgebung an einem Patienten
WO2007014004A2 (en) * 2005-07-21 2007-02-01 Johns Hopkins University Non-invasive mri measurement of tissue glycogen
WO2008105961A2 (en) * 2006-10-10 2008-09-04 Mayo Foundation For Medical Education And Research Reducing contrast agent-induced toxicity
US20100209356A1 (en) * 2007-10-12 2010-08-19 Duncan George Wynn Contrast agents
US8323619B2 (en) * 2007-11-07 2012-12-04 Ge Healthcare As Contrast agents
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
JP2011506286A (ja) * 2007-12-05 2011-03-03 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
WO2009106552A2 (en) * 2008-02-27 2009-09-03 Ge Healthcare As Contrast agents
EP2243767A1 (de) * 2009-04-21 2010-10-27 Bracco Imaging S.p.A Verfahren zur Iodierung aromatischer Verbindungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
ES2165971T3 (es) * 1995-02-24 2002-04-01 Bracco Research Sa Suspensiones de liposomas como agentes de contraste para la imagineria de la sangre.
US5648536A (en) * 1995-06-07 1997-07-15 Dunn; Thomas Jeffrey Process for producing ioversol
RU2207808C2 (ru) 1998-04-09 2003-07-10 Амершем Хелт АС Применение контрастных агентов в форме частиц в диагностической визуализации для изучения физиологических параметров
AU4656400A (en) * 1999-04-21 2000-11-17 Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The Method for enhancing contrast produced by mri
FR2794744B1 (fr) * 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale

Also Published As

Publication number Publication date
DE60216770T2 (de) 2007-04-12
JP4310187B2 (ja) 2009-08-05
WO2003013616A8 (en) 2004-04-08
ITMI20011706A1 (it) 2003-02-03
DE60216770D1 (de) 2007-01-25
WO2003013616A1 (en) 2003-02-20
JP2005505527A (ja) 2005-02-24
EP1411992B1 (de) 2006-12-13
ES2278946T3 (es) 2007-08-16
EP1411992A1 (de) 2004-04-28
DK1411992T3 (da) 2007-04-10
US20050113675A1 (en) 2005-05-26
US8211404B2 (en) 2012-07-03
ITMI20011706A0 (it) 2001-08-03

Similar Documents

Publication Publication Date Title
NO991688D0 (no) Administrerbare sammensetninger og fremgangsmÕter til magnetisk resonansavbildning
Gorelik et al. Early detection of metastases using whole-body MRI for initial staging and routine follow-up of myxoid liposarcoma
BR9708470A (pt) Agentes de contraste bioativados para formação de imagem para diagnósticos
ATE347912T1 (de) Ionisches und nicht-ionisches radiographisches kontrastmittel zur verwendung in der kombinierten roentgen- und kernspintomographiediagnostik
DE60035240D1 (de) Marker für Computertomografie und MRI-Bilderzeugung
DE69941912D1 (de) Amphipatische Polycarboxylchelaten und Komplexen mit paramagnetischen Metallen als MRI kontrastmitteln
IS4790A (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
PL309395A1 (en) Injectable aqueous preparations useful in x-ray diagnostics, containing iodised aromatic compounds used as x-raying contrast media
ITSV980052A0 (it) Lettino porta paziente o simili, e macchina, in particolare per il rilevamento d'immagini in risonanza magnetica nucleare in conbinazione
PL323919A1 (en) Free heterocyclic methyl radicals as agent improving imaging
ATE195432T1 (de) Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
ATE519505T1 (de) Reaktive paramagnetische kontrastmittel für magnetresonanzbildgebung
ATE345355T1 (de) Peptidkonjugate, deren derivate mit metallischen komplexen und deren verwendung zur bildgebenden magnetischen resonanz
NO940115D0 (no) Kontrastmidler for roentgen- og magnettomografisk avbildning
ES2117670T3 (es) Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes.
EP1355913A4 (de) Komplexverbindungen aus paramagnetischem metall und phthalocyanin und kontrastmittel, bei dem diese verbindungen verwendet werden
BR9508435A (pt) Quelentes macrocíclicos seus quelatos e usos dos mesmos no campo diagnóstico
Moelker et al. Interventional MR imaging at 1.5 T: quantification of sound exposure
DK0759785T3 (da) Liposomsuspensioner som blodkontrastmidler
EP1749026A4 (de) Markierte adrenomedullinderivate und deren verwendung zur bilddarstellung und therapie
Rathebe Occupational exposure to static magnetic fields from MRI units in health care settings: a narrative review
DE602004022301D1 (de) Glycerophosphocholin und derivate davon zur medizinischen abbildung von neuropsychiatrischen erkrankungen
JPH0360642A (ja) 定位脳手術装置
Akutagawa et al. A computer simulation of the metallic artifacts in MRI caused by dental magnetic attachments
Khazaee et al. Micro-CT imaging technique to characterize diffusion of small-molecules

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1411992

Country of ref document: EP